Gujarat Terce Laboratories Hits 52-Week High, Outperforms Sector and Sensex
Gujarat Terce Laboratories, a microcap pharmaceutical company, has reached a 52-week high on September 17, 2024. The stock has been performing well, outperforming the sector by 4.85% and seeing a consecutive gain for the last 6 days. It has also shown a 293.50% increase in the past year, indicating strong potential for growth in the industry.
Gujarat Terce Laboratories, a microcap pharmaceutical company, has recently hit a 52-week high on September 17, 2024. The stock has been performing well in the market, with a 'Sell' call by MarketsMOJO.
The stock opened today at Rs.78.7, which is also its new 52-week and all-time high. It has outperformed the sector by 4.85% and has been on a consecutive gain for the last 6 days, with a 29.02% increase in returns during this period. The stock also opened with a gain of 4.78% today and touched an intraday high of Rs.78.7.
Gujarat Terce Laboratories is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
In the past year, the company's performance has been impressive, with a 293.50% increase, while the Sensex has only seen a 22.26% growth. This shows the company's strong performance and potential for growth in the pharmaceutical industry.
Investors and experts are keeping a close eye on Gujarat Terce Laboratories as it continues to make strides in the market. With its recent 52-week high and consistent gains, the company is proving to be a strong player in the microcap segment of the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
